Combating antimicrobial resistance (AMR)
AMR is a serious threat to cancer care, and if not addressed urgently, all the progress we have made in preventing and treating cancer will be seriously undermined – we need strong and effective collaboration now. As many as one in five cancer patients undergoing treatment are hospitalized due to infection, and antibiotics are the main line of defense. Increasing awareness and sharing best practices is a crucial first step. UICC has actively brought together the cancer and infectious diseases community to jointly address AMR and reduce the risk for people with cancer of dying from an infection. Addressing AMR must be included in cancer control policy and that’s what I fight for, particularly in leading the UICC task force on AMR and cancer care. This task force has been set up to address the challenges in cancer care due to AMR and provide the evidence base to mobilize policy change, especially on data and surveillance and access to appropriate treatments. Because all of us need to be resistance fighters.
Learn more at AntimicrobialResistanceFighters.org